Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CORONAVIRUS INFECTIOUS DISEASES
Document Type and Number:
WIPO Patent Application WO/2022/085806
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus (exclusive of SARS-CoV-2) infectious diseases, a food composition for prevention or alleviation of coronavirus (exclusive of SARS-CoV-2) infectious diseases, or an antiviral composition against coronaviruses (exclusive of SARS-CoV-2), each composition comprising a Justicia procumbens organic solvent extract, justicidin-A, justicidin-B, or 6' hydroxyjusticidin-B as an active ingredient. The compositions contain a Justicia procumbens anhydrous ethanol extract, and justicidin-A, justicidin-B, or 6' hydroxyjusticidin-B, which exhibit an excellent inhibitory effect against coronavirus, and as such, can effectively prevent, treat, or alleviate coronavirus infectious diseases.

Inventors:
HWANG YUN HA (KR)
LEE MA SE (KR)
JEONG DOC GYUN (KR)
Application Number:
PCT/KR2020/014283
Publication Date:
April 28, 2022
Filing Date:
October 19, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DONG WHA PHARM CO LTD (KR)
International Classes:
A61K36/19; A23L33/105; A61K31/365; A61P31/14
Foreign References:
KR20170118613A2017-10-25
KR20060040407A2006-05-10
Other References:
LAUXMANN MARTIN ALEXANDER, SANTUCCI NATALIA ESTEFANÍA, AUTRÁN-GÓMEZ ANA MARÍA: "The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak", INTERNATIONAL BRAZILIAN JOURNAL OF UROLOGY, SOCIEDADE BRASILEIRA DE UROLOGIA, BR, vol. 46, no. suppl 1, 1 January 2020 (2020-01-01), BR , pages 6 - 18, XP055924673, ISSN: 1677-5538, DOI: 10.1590/s1677-5538.ibju.2020.s101
ASANO JUN, KAZUHIRO CHIBA, MASAHIRO TADA, TAKAO YOSHII: "Antiviral activity of lignans and their glycosides from Justicia procumbens", PHYTOCHEMISTRY, vol. 42, no. 3, 1 June 1996 (1996-06-01), pages 713 - 717, XP055924677, DOI: 10.1016/0031-9422(96)00024-6
PARK, SANG-IK: "Dong Wha Pharm. Plans to Launch Phase 2 Clinical Trials in June for COVID-19 Treatment", 22 April 2020 (2020-04-22), pages 1 - 4, XP009536115, Retrieved from the Internet
DONG WHA PHARM. CO., LTD.: "New Drug Substance DW2008, Promotion of COVID-19 Clinical Trials", THE HERALD BUSINESS, pages 1 - 1, XP009536119, Retrieved from the Internet
Attorney, Agent or Firm:
AHN, So Young (KR)
Download PDF: